Ohno R - Search Results

1

A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignancies.

Yamada K, Shirakawa S, Ohno R, Yamada H, Hirota Y, Ohara K, Yamagata K, Kobayashi M, Hirano M, Ikeda Y, et al. Yamada K, et al. Among authors: ohno r. Invest New Drugs. 1987;5(3):299-305. doi: 10.1007/BF00175302. Invest New Drugs. 1987. PMID: 3667166

2

Phase II study: treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine).

Ohno R, Yamada K, Hirano M, Shirakawa S, Tanaka M, Oguri T, Kodera Y, Mitomo Y, Ikeda Y, Yokomaku S, et al. Ohno R, et al. J Natl Cancer Inst. 1992 Mar 18;84(6):435-8. doi: 10.1093/jnci/84.6.435. J Natl Cancer Inst. 1992. PMID: 1538420 Clinical Trial.

3

[Phase II study of SM-108 (4-carbamoylimidazolium-5-olate) in hematological malignancies].

Kimura K, Yamada K, Uzuka Y, Masaoka T, Hirano M, Ohno R, Ogawa M. Kimura K, et al. Among authors: ohno r. Gan To Kagaku Ryoho. 1989 Jan;16(1):123-30. Gan To Kagaku Ryoho. 1989. PMID: 2643392 Clinical Trial. Japanese.

4

Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.

Ohno R, Kimura K, Amaki I, Hirano M, Hoshino A, Ikeda Y, Kimura I, Kobayashi M, Konno K, Majima H, et al. Ohno R, et al. Cancer Chemother Pharmacol. 1987;20(3):230-4. doi: 10.1007/BF00570491. Cancer Chemother Pharmacol. 1987. PMID: 3315282 Clinical Trial.

5

[Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].

Ota K, Ohno R, Shirakawa S, Masaoka T, Okada K, Ohashi Y, Taguchi T. Ota K, et al. Among authors: ohno r. Gan To Kagaku Ryoho. 1994 Jun;21(7):1047-55. Gan To Kagaku Ryoho. 1994. PMID: 8210256 Clinical Trial. Japanese.

6

A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia-lymphoma.

Ezaki K, Hirano M, Ohno R, Yamada K, Naito K, Hirota Y, Shirakawa S, Kimura K. Ezaki K, et al. Among authors: ohno r. Cancer. 1991 Aug 15;68(4):695-8. doi: 10.1002/1097-0142(19910815)68:4<695::aid-cncr2820680405>3.0.co;2-k. Cancer. 1991. PMID: 1855169 Clinical Trial.

7

[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma].

Yamada K, Ohno R, Oguri T, Kamiya O, Yokomaku S, Kobayashi M, Nishiwaki H, Tanaka M, Inagaki J, Mitomo Y, et al. Yamada K, et al. Among authors: ohno r. Gan To Kagaku Ryoho. 1991 Nov;18(14):2447-52. Gan To Kagaku Ryoho. 1991. PMID: 1952964 Japanese.

8

[Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].

Naito K, Kobayashi M, Okumura M, Ikeda Y, Mitomo Y, Oguri T, Tanaka M, Ohara K, Kodera Y, Ohno R, et al. Naito K, et al. Among authors: ohno r. Jpn J Antibiot. 1990 Aug;43(8):1371-80. Jpn J Antibiot. 1990. PMID: 2283705 Clinical Trial. Japanese.

9

[Phase II study of carboplatin in malignant lymphoma].

Naito K, Kobayashi M, Oyama A, Kodera Y, Tanaka M, Kamiya O, Mitomo Y, Ohno R, Sampi K, Hirano M, et al. Naito K, et al. Among authors: ohno r. Gan To Kagaku Ryoho. 1988 Jul;15(7):2145-51. Gan To Kagaku Ryoho. 1988. PMID: 3293537 Japanese.

10

[Early phase II trial of bestrabucil in hematological malignancies].

Nagura E, Ohno R, Yamada K, Akao Y, Naito K, Nishikawa M, Tanaka H, Shirakawa S, Ono Y, Ezaki K, et al. Nagura E, et al. Among authors: ohno r. Gan To Kagaku Ryoho. 1986 Jun;13(6):2216-22. Gan To Kagaku Ryoho. 1986. PMID: 3459398 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

631 results

Search Page

Filters